Isolated BAP1 loss in malignant pleural mesothelioma predicts immunogenicity with implications for immunotherapeutic response
Hatice U. Osmanbeyoglu, Drake Palmer, April Sagan, Eleonora Sementino, Michael John Becich, Joseph R. Testa
The paper identifies BAP1 loss as a predictor of immunogenicity and potential response to PD-1 therapy in malignant pleural mesothelioma.
Cancers · Nov 16, 2022Peer-reviewedBioinformatics